IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

MWG Management Ltd.

Q1 2023 Holdings

Filed 2023-05-15 | 3 holdings | $142.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Beam Therapeutics Inc(BEAM)COM07373V105$71.9M2,346,93450.6%
Lyell Immunopharma IncCOM55083R104$47.6M20,162,33233.5%
Prime Medicine Inc(PRME)COM74168J101$22.6M1,835,87615.9%